Paper40106404
Identification of distinct profiles of glioblastoma through the immunocapture of extracellular vesicles from patient plasma.
Manu DR and 7 others. PLoS One, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Identification of distinct profiles of glioblastoma through the immunocapture of extracellular vesicles from patient plasma. Papers, record 40106404. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40106404
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Identification of distinct profiles of glioblastoma through the immunocapture of extracellular vesicles from patient plasma.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Extracellular Vesicles | Major topic |
| Glioblastoma | Major topic |
| Brain Neoplasms | Major topic |
| Humans | |
| Male | |
| Biomarkers, Tumor | |
| Female | |
| Middle Aged | |
| Flow Cytometry | |
| Principal Component Analysis | |
| Adult | |
| Case-Control Studies | |
| Aged |
Source PubMed
References80
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24607407 | Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth. | Cell Stem Cell | 2014 | https://conductscience.org/library/papers/24607407 | PubMed |
| 2 | 25978997 | Expression of stage-specific embryonic antigen-4 (SSEA-4) defines spontaneous loss of epithelial phenotype in human solid tumor cells. | Glycobiology | 2015 | https://conductscience.org/library/papers/25978997 | PubMed |
| 3 | 37894408 | CD44 Intracellular Domain: A Long Tale of a Short Tail. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37894408 | PubMed |
| 4 | 32946518 | Transcriptomics predicts compound synergy in drug and natural product treated glioblastoma cells. | PLoS One | 2020 | https://conductscience.org/library/papers/32946518 | PubMed |
| 5 | 35477770 | Description and optimization of a multiplex bead-based flow cytometry method (MBFCM) to characterize extracellular vesicles in serum samples from patients with hematological malignancies. | Cancer Gene Ther | 2022 | https://conductscience.org/library/papers/35477770 | PubMed |
| 6 | 32641768 | Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy. | Nat Commun | 2020 | https://conductscience.org/library/papers/32641768 | PubMed |
| 7 | 34445097 | Reviewing the Significance of Blood-Brain Barrier Disruption in Multiple Sclerosis Pathology and Treatment. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34445097 | PubMed |
| 8 | 30992437 | Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment. | Nat Commun | 2019 | https://conductscience.org/library/papers/30992437 | PubMed |
| 9 | 31147892 | CD146 is highly expressed in glioma stem cells and acts as a cell cycle regulator. | J Neurooncol | 2019 | https://conductscience.org/library/papers/31147892 | PubMed |
| 10 | 36275738 | Exosomes in the tumor microenvironment: Promoting cancer progression. | Front Immunol | 2022 | https://conductscience.org/library/papers/36275738 | PubMed |
| 11 | 24614622 | Molecular subtypes of glioblastoma are relevant to lower grade glioma. | PLoS One | 2014 | https://conductscience.org/library/papers/24614622 | PubMed |
| 12 | 36228964 | Signaling pathways governing glioma cancer stem cells behavior. | Cell Signal | 2023 | https://conductscience.org/library/papers/36228964 | PubMed |
| 13 | 36713536 | Human macrophage-engineered vesicles for utilization in ovarian cancer treatment. | Front Oncol | 2022 | https://conductscience.org/library/papers/36713536 | PubMed |
| 14 | 28536635 | The regulatory mechanisms of NG2/CSPG4 expression. | Cell Mol Biol Lett | 2017 | https://conductscience.org/library/papers/28536635 | PubMed |
| 15 | 33287106 | The miRNA Content of Exosomes Released from the Glioma Microenvironment Can Affect Malignant Progression. | Biomedicines | 2020 | https://conductscience.org/library/papers/33287106 | PubMed |
| 16 | 26923195 | Targeting ROR1 inhibits the self-renewal and invasive ability of glioblastoma stem cells. | Cell Biochem Funct | 2016 | https://conductscience.org/library/papers/26923195 | PubMed |
| 17 | 32942567 | Mesenchymal Stromal-Like Cells in the Glioma Microenvironment: What Are These Cells? | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32942567 | PubMed |
| 18 | 32817412 | Immune profiling of plasma-derived extracellular vesicles identifies Parkinson disease. | Neurol Neuroimmunol Neuroinflamm | 2020 | https://conductscience.org/library/papers/32817412 | PubMed |
| 19 | 36369033 | Understanding the versatile roles and applications of EpCAM in cancers: from bench to bedside. | Exp Hematol Oncol | 2022 | https://conductscience.org/library/papers/36369033 | PubMed |
| 20 | 20145155 | Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin. | Cancer Res | 2010 | https://conductscience.org/library/papers/20145155 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42511618 | Extracellular Vesicles as Master Regulators of Immune Modulation in Multiple Myeloma. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511618 | PubMed |
| 42336206 | Extracellular Vesicles From Glioblastoma Cells Reflect 2D vs. 3D Culture Adaptation and Resistance to Temozolomide. | Mol Cell Proteomics | 2026 | https://conductscience.org/library/papers/42336206 | PubMed |
| 41788738 | The glioblastoma GBMdrug1000 dataset resource provides directions for future small molecule drug discovery. | Neurooncol Adv | 2026 | https://conductscience.org/library/papers/41788738 | PubMed |
| 41750189 | 'Molecular and Cellular Neuroscience': Impacts of Eight Highly Cited Articles Published in This Section of Brain Sciences in 2024. | Brain Sci | 2026 | https://conductscience.org/library/papers/41750189 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ITGB1 | 3688 | PubTator's text mining | https://conductscience.org/library/genes/3688 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40106404
GET https://conductscience.org/api/papers/v1/40106404/references?page=2